Structure Therapeutics Inc. Sponsored ADR (GPCR)
(Delayed Data from NSDQ)
$23.58 USD
+0.35 (1.51%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $26.00 +2.42 (10.26%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Structure Therapeutics Inc. Sponsored ADR has a market cap of $1.34B, which represents its share price of $23.23 multiplied by its outstanding shares number of 57.60M. As a small-cap company, GPCR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GPCR 23.58 +0.35(1.51%)
Will GPCR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GPCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GPCR
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
GPCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for October 23rd
Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?
Other News for GPCR
Crossed Above 200 Day Moving Average appears for GPCR after 7.3% move
Structure Therapeutics (GPCR) Shares Cross Above 200 DMA
New Uptrend appears for GPCR after 0.64% move
Promising Market Potential for Structure Therapeutics: Buy Rating Backed by Superior Trial Results and Market Opportunities
Cantor Fitzgerald Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)